about
Potential of Liposomes for Enhancement of Oral Drug Absorption.EGFR targeted thermosensitive liposomes: A novel multifunctional platform for simultaneous tumor targeted and stimulus responsive drug delivery.Utilization of chitosan-caged liposomes to push the boundaries of therapeutic delivery.9-nitrocamptothecin polymeric nanoparticles: cytotoxicity and pharmacokinetic studies of lactone and total forms of drug in rats.Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection.Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.Simultaneous determination of a new antituberculosis agent KBF-611 and its de-acetylated metabolite in mouse and rabbit plasma by HPLC.Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice.Sirolimus-loaded stealth colloidal systems attenuate neointimal hyperplasia after balloon injury: a comparison of phospholipid micelles and liposomes.Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug.LC determination of piroxicam in human plasma.A high performance liquid chromatography method for simultaneous determination of albendazole metabolites in human serum.Dose dependent pharmacokinetics of albendazole in human.Liquid chromatographic quantitation of the lactone and the total of lactone and carboxylate forms of 9-nitrocamptothecin in human plasma.Simple and sensitive high performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of topotecan in human plasma.A Novel Combined Approach of Short-Chain Sphingolipids and Thermosensitive Liposomes for Improved Drug Delivery to Tumor Cells.Physicochemical characteristics of liposomes are decisive for their antirestenosis efficacy following local delivery.The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.Doxorubicin-loaded liposomes: enhancing the oral bioavailability by modulation of physicochemical characteristics.Radiolabeling of Preformed Niosomes with [Tc]: In Vitro Stability, Biodistribution, and In Vivo PerformanceEffects of cyclosporine A on the hepatobiliary disposition and hepatic uptake of etoposide in an isolated perfused rat liver modelAn isocratic high-performance liquid chromatographic system for simultaneous determination of theophylline and its major metabolites in human urineEncapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kineticsPEGylated estradiol benzoate liposomes as a potential local vascular delivery system for treatment of restenosisUse of remote film loading methodology to entrap sirolimus into liposomes: preparation, characterization and in vivo efficacy for treatment of restenosisMarked effects of combined TPGS and PVA emulsifiers in the fabrication of etoposide-loaded PLGA-PEG nanoparticles: in vitro and in vivo evaluationEffective attenuation of vascular restenosis following local delivery of chitosan decorated sirolimus liposomesPharmacokinetics, Tissue Distribution and Excretion of Ag2S Quantum Dots in Mice and Rats: the Effects of Injection Dose, Particle Size and Surface ChargeBCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney DiseaseTuning the Physicochemical Characteristics of Particle-Based Carriers for Intraperitoneal Local Chemotherapy
P50
Q38697012-9E150A67-F4BD-4562-8B8A-ECFE2760E9BCQ38756989-954323E6-8D09-4F00-876F-AA1FFFE65D47Q39042111-EA9C437B-09C2-4C1C-A3EA-F0C9E1F438AEQ39952471-84D1C2B0-F3CE-48A7-A4F5-39087B4765F3Q40823219-73E184D9-1750-4604-98E7-92480BD29AC2Q41871280-CDC7D975-180E-4556-8DAA-8B8B7429087EQ43246007-773D2943-FC95-4A68-AEFA-2F96A71CE491Q43281285-9DABBE9D-29DB-42D1-B643-9321CF7125BBQ43750221-886206A9-99EC-4867-BC8D-98899B9BEC94Q43993972-7907C59C-3703-4AFF-BA1E-6CA9A08EDA15Q44017956-E3A221C2-2E34-44E4-A706-908977D5F7D7Q44199734-C8BEB528-8849-415C-A4F5-C0E06B17320DQ44240842-4585E433-7717-4198-AA27-EC213EEA5FC7Q45284724-F1C1CB23-C78B-43FE-ABD0-E14EC53DE3BDQ45284728-E42A1341-4F3F-4921-A8BA-45909BD87D41Q50797989-71D8DDA1-5373-482D-8012-DB6294019811Q51309922-B2C8AEAC-50D5-49D4-9460-FA23F1F99C94Q51792145-4CF230C4-5B2D-45A9-9384-D913FC05E58DQ53329400-F23E90AC-92D1-4091-BD27-7F8535BCFB20Q57020794-D997411A-9DB1-47AD-BFAA-B8DA186CEED7Q57145049-620D8B03-43C6-4C13-AE98-AECF9E391884Q71489047-A56CE8AC-58A3-4B07-8B00-DF5F462801CDQ79312009-B2B903A1-C021-4AC0-80AB-DF9C09BDF2FEQ82309954-1240F58C-6226-40EA-8912-B63DB5D87378Q84068692-FB528F95-83E6-43EA-90D8-4FEA0AC05865Q87144186-472B69B8-4C2E-492E-BD3E-99D24307016FQ89003546-C295F699-9E00-48F9-A2D5-B6771FEFDB0CQ91343889-2F94D566-0F6A-4CCC-922C-4E1C885E1440Q94525951-6445121E-9B1A-408D-AFA2-A278AFC2F06BQ96138656-40015E1C-FBE6-4FF8-8FA0-E6D5C735655B
P50
description
researcher
@en
wetenschapper
@nl
name
S Dadashzadeh
@en
S Dadashzadeh
@nl
type
label
S Dadashzadeh
@en
S Dadashzadeh
@nl
prefLabel
S Dadashzadeh
@en
S Dadashzadeh
@nl
P106
P31
P496
0000-0003-1420-8796